Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-transplant Hepatitis C”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Testing effectiveness (Phase 2)Ended earlyNCT00582738
What this trial is testing

Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection

Who this might be right for
Recurrent Hepatitis C
Novartis Pharmaceuticals 43
Post-approval studies (Phase 4)Ended earlyNCT03207399
What this trial is testing

Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment

Who this might be right for
Hepatitis C, ChronicLung Transplant
Duke University 1
Large-scale testing (Phase 3)Study completedNCT02966795
What this trial is testing

Of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 84
Large-scale testing (Phase 3)Study completedNCT01707849
What this trial is testing

The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation

Who this might be right for
Hepatitis C Recurrence After Liver Transplant
Hospital Vall d'Hebron 18
Post-approval studies (Phase 4)Study completedNCT00383864
What this trial is testing

Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation.

Who this might be right for
Hepatitis C
Hospital Clinic of Barcelona 55
Testing effectiveness (Phase 2)Study completedNCT02165189
What this trial is testing

An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant

Who this might be right for
Hepatitits C
Janssen Scientific Affairs, LLC 46
Post-approval studies (Phase 4)Ended earlyNCT03723824
What this trial is testing

Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney Transplantation

Who this might be right for
Chronic Hepatitis cLiver Transplant InfectionKidney Transplant Infection
Taichung Veterans General Hospital 14
Testing effectiveness (Phase 2)Study completedNCT00668369
What this trial is testing

Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation

Who this might be right for
Hepatitis C Virus InfectionLiver Transplantation
Hospital Clinic of Barcelona 34
Post-approval studies (Phase 4)Ended earlyNCT00260208
What this trial is testing

Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus

Who this might be right for
Liver TransplantHepatitis C
Novartis Pharmaceuticals 361
Large-scale testing (Phase 3)Study completedNCT01571583
What this trial is testing

An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection
Janssen-Cilag International NV 74
Testing effectiveness (Phase 2)Study completedNCT01559844
What this trial is testing

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

Who this might be right for
Hepatitis CHepatocellular Carcinoma
Gilead Sciences 61
Testing effectiveness (Phase 2)Study completedNCT03523871
What this trial is testing

The Use of Hepatitis C Positive Donors for Hepatitis C Negative Lung Transplant Recipients With Post-transplant Treatment With Mavyret

Who this might be right for
Hepatitis C
NYU Langone Health 20
Large-scale testing (Phase 3)Study completedNCT02692703
What this trial is testing

Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2)

Who this might be right for
Chronic Hepatitis CHCVHepatitis C Virus
AbbVie 100
Not applicableUnknownNCT00701272
What this trial is testing

FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation

Who this might be right for
Liver TransplantationHepatitis C
University Health Network, Toronto 70
Post-approval studies (Phase 4)Study completedNCT03133065
What this trial is testing

Early Treatment of Recurrent HCV- Infection Post Liver Transplantation in the Era of DAAs

Who this might be right for
Liver Transplantation
Ain Shams University 89
Post-approval studies (Phase 4)UnknownNCT03359746
What this trial is testing

Grazoprevir/Elbasvir for Treatment of Hepatitis C Virus Genotype 4 Post Kidney Transplant

Who this might be right for
Hepatitis C
King Faisal Specialist Hospital & Research Center 40
Post-approval studies (Phase 4)Study completedNCT00087633
What this trial is testing

PHOENIX Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) Administered After Liver Transplantation for Hepatitis C.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 115
Testing effectiveness (Phase 2)Study completedNCT01022476
What this trial is testing

Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients

Who this might be right for
HIV InfectionLiver FailureEvidence of Liver Transplantation
ANRS, Emerging Infectious Diseases 14
Large-scale testing (Phase 3)Study completedNCT00151580
What this trial is testing

Treatment of Recurrent Hepatitis C After Liver Transplantation

Who this might be right for
Liver TransplantationHepatitis C
Rennes University Hospital 200
Not applicableApproved For MarketingNCT01779518
What this trial is testing

Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C

Who this might be right for
Post-transplant Hepatitis C
Gilead Sciences
Load More Results